CAECUM PERFORATION CAUSED BY MYCOPHENOLATE MOFETIL (MMF) AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Karagun, B. [1 ]
Akbas, T. [2 ]
Arpaci, T. [2 ]
Ozcan, N. [2 ]
Cesur, I. [3 ]
Serbest, M. [1 ]
Sasmaz, I. [1 ]
Antmen, B. [1 ]
机构：
[1] Adana Acibadem Pediat Hematol Oncol & Bone Marrow, Adana, Turkey
[2] Adana Acibadem Radiol Unit, Adana, Turkey
[3] Adana Numune Hosp Pediat Surg, Adana, Turkey
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP-184
引用
收藏
页码：SS41 / SS41
页数：1
相关论文
共 50 条
  • [1] Mycophenolate mofetil (MMF) in pediatric renal transplantation
    Ojogho, O
    Sahney, S
    Wells, M
    Culler, D
    Deming, D
    Cao, S
    Concepcion, W
    TRANSPLANTATION, 1999, 67 (09) : S642 - S642
  • [2] Mycophenolate mofetil (MMF) depresses antibody production after cardiac transplantation
    Rose, ML
    Danskine, A
    Smith, JD
    Keogh, AM
    Dureau, G
    Kobashigawa, JA
    Dunn, MJ
    CIRCULATION, 2000, 102 (18) : 490 - 490
  • [3] Cecum perforation induced by mycophenolate mofetil after hematopoietic stem cell transplantation: A case report and review of literature
    Karagun, Barbaros Sahin
    Akbas, Tugana
    Arpaci, Taner
    Antmen, Bulent
    PEDIATRIC TRANSPLANTATION, 2018, 22 (06)
  • [4] Mycophenolate mofetil (MMF) for treatment of chronic GVHD (cGVHD) following hematopoietic stem cell transplantation (HSCT).
    Busca, A
    Falda, M
    Locatelli, F
    Boccomini, C
    Ceretto, C
    Dall'Omo, AM
    Gallo, E
    BLOOD, 2002, 100 (11) : 847A - 848A
  • [5] Acute Pulmonary Toxicity By Mycophenolate Mofetil (MMF) after Haploidentical Stem Cell Transplant (SCT)
    Mehta, Rohtesh S.
    Brammer, Jonathan
    Shpall, Elizabeth J.
    Champlin, Richard E.
    BLOOD, 2014, 124 (21)
  • [6] Intravenous mycophenolate mofetil (MMF) after allogeneic blood stem cell transplantation.: Results of a dose-finding study.
    Renner, U
    Platzbecker, U
    Freiberg-Richter, J
    Plettig, R
    Helwig, A
    Schäfer, K
    Wandt, H
    Ehninger, G
    Bornhauser, M
    BLOOD, 1999, 94 (10) : 156A - 156A
  • [7] Unrelated peripheral blood stem cell (PBSC) transplantation after nonmyeloablative conditioning: BID vs. TID mycophenolate mofetil (MMF).
    Maris, MB
    Sandmaier, BM
    Stuart, M
    Agura, E
    Hegenbart, U
    Pulsipher, M
    Mazierz, R
    Bruno, B
    McSweeney, P
    Maloney, D
    Niederwieser, D
    Blume, K
    Storb, R
    BLOOD, 2003, 102 (11) : 475B - 475B
  • [8] Pharmacokinetics of Mycophenolate Mofetil (MMF) in Lung Transplantation: Comparison with Renal Transplantation
    de Winter, B. C. M.
    Monchaud, C.
    Premaud, A.
    Pison, C.
    Kessler, R.
    Reynaud-Gaubert, M.
    Dromer, C.
    Stern, M.
    Guillemain, R.
    Knoop, C.
    Estenne, M.
    Marquet, P.
    Rousseau, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S141 - S141
  • [9] Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation
    Jenke, A
    Renner, U
    Richter, M
    Freiberg-Richter, J
    Platzbecker, U
    Helwig, A
    Thiede, HM
    Schäfer-Eckart, K
    Ehninger, G
    Bornhauser, M
    CLINICAL TRANSPLANTATION, 2001, 15 (03) : 176 - 184
  • [10] Does Split Dosing of Mycophenolate Mofetil (MMF) Impact Efficacy after Renal Transplantation?
    Campara, Maya
    Thielke, James J.
    West-Thielke, Patricia M.
    Herren, Heather
    Ommert, Thuy
    Tang, Ignatius Y. S.
    Oberholzer, Jose
    Benedetti, Enrico
    Kaplan, Bruce
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 432 - 432
12345